Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys (Q40546858)

21 September 2017

title

Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys (English)

1 reference

21 September 2017

0 references

1 reference

Ricardo Galler

1 reference

21 September 2017

Renato Sérgio Marchevsky

series ordinal

object named as

Renato S. Marchevsky

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599790

28 March 2024

Evandro S. F. Coutinho

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599790

28 March 2024

Marcos S. Freire

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599790

28 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

21 September 2017

10 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14599790

full work available at URL

28 March 2024

https://www.arca.fiocruz.br/bitstream/icict/32236/2/F110-1-s2.0-S004268220300583X-main.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599790

https://api.elsevier.com/content/article/PII:S004268220300583X?httpAccept=text/xml

28 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0042-6822(03)00583-X

https://api.elsevier.com/content/article/PII:S004268220300583X?httpAccept=text/plain

28 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0042-6822(03)00583-X

28 March 2024

1 reference

21 September 2017

volume

316

1 reference

21 September 2017

1 reference

21 September 2017

page(s)

55-63

1 reference

Hepatitis and death following vaccination with 17D-204 yellow fever vaccine

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900583-X

7 January 2021

Genetic variability among yellow fever virus 17D substrains

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900583-X

7 January 2021

Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900583-X

7 January 2021

Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900583-X

7 January 2021

Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900583-X

7 January 2021

Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900583-X

7 January 2021

The monkey safety test for neurovirulence of yellow fever vaccines: the utility of quantitative clinical evaluation and histological examination

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900583-X

7 January 2021

Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900583-X

7 January 2021

Ontogeny of Yellow Fever 17D Vaccine: RNA Oligonucleotide Fingerprint and Monoclonal Antibody Analyses of Vaccines Produced World-wide

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900583-X

7 January 2021

Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900583-X

7 January 2021

Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900583-X

7 January 2021

Histological studies of the monkey neurovirulence of group B arboviruses. 3. Relative virulence of selected viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900583-X

7 January 2021

The early use of yellow fever virus strain 17D for vaccine production in Brazil--a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900583-X

7 January 2021

Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900583-X

7 January 2021

Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900583-X

7 January 2021

Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900583-X

7 January 2021

Pathophysiologic correlations in a rhesus monkey model of yellow fever with special observations on the acute necrosis of B cell areas of lymphoid tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900583-X

7 January 2021

Phenotypic Analysis of Yellow Fever Virus Derived from Complementary DNA

1 reference

https://api.crossref.org/works/10.1016/S0042-6822(03)00583-X

Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine

28 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0042-6822(03)00583-X

28 March 2024

Identifiers

DOI

1 reference

21 September 2017

1 reference